NMTC · Stage, GEX levels and seasonality
NeuroOne Medical Technologies Corporation Common Stock (NMTC)
Last close $1.03 (-5.5%) on 2026-09-30
No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.
Open the chartWeinstein stage
Stage 4B — Declining · 19 weeks in this stage · 30-week average $3.21
Stage 4 (declining): price stays below a falling 30-week average. The stage Weinstein avoids.
What would change it: Stage 1 begins when the 30-week SMA (3.21) stops declining and price starts closing above it.
GEX levels
Call wall, put wall and gamma flip for NMTC are on Signa plans. What GEX levels tell you.
Seasonality
| Month | Average return | Months up | Years |
|---|---|---|---|
| January | +10% | 75% | 4 |
| February | -8.86% | 25% | 4 |
| March | -8.96% | 50% | 4 |
| April | +4.03% | 25% | 4 |
| May | -16.17% | 0% | 4 |
| June | -3.26% | 50% | 4 |
| July | -14.45% | 25% | 4 |
| August | -1.7% | 50% | 4 |
| September | +3.69% | 75% | 4 |
| October (this month) | -5.87% | 0% | 3 |
| November | +6.14% | 33% | 3 |
| December | +26.41% | 100% | 3 |
Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.
On Signa plans
The Signa score and Action Card for NMTC, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.
No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.
Questions about NMTC
What Weinstein stage is NMTC in?
NMTC is in Stage 4B — Declining, for 19 weeks, based on completed weekly bars and its 30-week moving average (3.21).
How has NMTC done in October?
Over the last 3 years, NMTC averaged -5.87% in October and rose in 0% of them. Past seasonality does not predict future returns.
Educational content only, not financial advice. Trading involves substantial risk.